Search research articles
Contact Us
Filters
Showing results (231-240 of 293) with videos related to
Page
of 30
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin
K Obata, Y Ohashi, H Akaza, et al.
European Urology
|
January 1, 1988
Clinical evaluation of urethral tumors based on a simple classification system
H Akaza, Y Homma, K Koiso, et al.
Japanese Journal of Clinical Oncology
|
December 1, 1988
A prospective, randomized controlled study on the treatment of stage C and stage D prostatic cancer with estracyt in combination with other chemotherapeutic agents
H Akaza, K Isurugi, Y Oishi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
October 1, 1985
[Clinical application of extracorporeal shock wave lithotripter]
T Niijima, K Isurugi, T Umeda, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
October 1, 1988
[Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen]
M Usami, T Kotake, M Matsuda, et al.
Japanese Journal of Clinical Oncology
|
January 5, 2002
Treated natural history of superficial bladder cancer
S Ozono, S Hinotsu, S Tabata, et al.
Japanese Journal of Clinical Oncology
|
December 1, 1992
Comparison of various assay systems for prostate-specific antigen standardization
M Kuriyama, S Akimoto, H Akaza, et al.
Prostate Cancer and Prostatic Diseases
|
July 15, 2009
Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers
M Tanaka, K Fujimoto, Y Chihara, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
November 1, 1990
[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR]
T Niijima, Y Aso, H Akaza, et al.
The Journal of International Medical Research
|
January 1, 1990
Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group
H Akaza, Y Aso, K Koiso, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 293) with videos related to
Sort By:
Page
of 30
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin
K Obata, Y Ohashi, H Akaza, et al.
European Urology
|
January 1, 1988
Clinical evaluation of urethral tumors based on a simple classification system
H Akaza, Y Homma, K Koiso, et al.
Japanese Journal of Clinical Oncology
|
December 1, 1988
A prospective, randomized controlled study on the treatment of stage C and stage D prostatic cancer with estracyt in combination with other chemotherapeutic agents
H Akaza, K Isurugi, Y Oishi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
October 1, 1985
[Clinical application of extracorporeal shock wave lithotripter]
T Niijima, K Isurugi, T Umeda, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
October 1, 1988
[Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen]
M Usami, T Kotake, M Matsuda, et al.
Japanese Journal of Clinical Oncology
|
January 5, 2002
Treated natural history of superficial bladder cancer
S Ozono, S Hinotsu, S Tabata, et al.
Japanese Journal of Clinical Oncology
|
December 1, 1992
Comparison of various assay systems for prostate-specific antigen standardization
M Kuriyama, S Akimoto, H Akaza, et al.
Prostate Cancer and Prostatic Diseases
|
July 15, 2009
Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers
M Tanaka, K Fujimoto, Y Chihara, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
November 1, 1990
[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR]
T Niijima, Y Aso, H Akaza, et al.
The Journal of International Medical Research
|
January 1, 1990
Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group
H Akaza, Y Aso, K Koiso, et al.
Page
of 30